55513-0207 MVASI - CanMED: NDC

Product NDC:

55513-0207

Brand Name:

MVASI

Generic Name:

Bevacizumab-awwb

Dosage Form Name:

INJECTION, SOLUTION

Administration Route:

Intravenous

Substances:

Name: BEVACIZUMAB

Strength: 400.0

Unit: mg/16mL

Name: BEVACIZUMAB

Strength: 400.0

Unit: mg/16mL

Packages:

Code: 55513-0207-01

Description: 1 VIAL in 1 CARTON (55513-207-01) / 16 mL in 1 VIAL

Effective Date: June 1, 2018

Discontinued:

Code: 55513-0207-21

Description: 1 VIAL in 1 CARTON (55513-207-21) / 16 mL in 1 VIAL

Effective Date: June 27, 2025

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

Monoclonal Antibody

Minor Class:

VEGFR

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox